Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...

The consolidated evidence reveals that there is considerable cross-country price variation, particularly for second-line regimens where prices increase significantly with income level highlighting ...

The gutting of HIV drug programs isn't just bad policy; it threatens a repeat of history's deadliest mistake, writes John ...

National Week of Prayer for the Healing of AIDS brings faith communities together for prayer, education, and advocacy to ...